Trade Bioventus Inc. - BVS CFD

Trading Conditions

• Type: CFD
• Spread: 0.09
• Long position overnight funding adjustment: -0.02165%
• Short position overnight funding adjustment: -0.00057%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 5.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 9.09
• Open: 9.12
• 1-Year Change: 0.22%
• Day's Range: 9.05 - 9.32

Trade Bioventus Inc. - BVS CFD

What is Bioventus Inc. (BVS)?

Bioventus Inc. is a global medical device company specializing in orthobiologics, which are biological materials used to aid in the healing of musculoskeletal injuries. The company develops and markets products designed to improve bone healing, joint health, and pain management. Bioventus focuses on therapies that support tissue repair and regeneration, including bone graft substitutes and other biologic treatments. Its offerings are utilized by healthcare professionals in orthopedic, sports medicine, and trauma settings. The company operates in multiple international markets, emphasizing innovation and clinical research to advance patient care in musculoskeletal health.

Bioventus Inc. Stock Price Today: Live Overview

The price today is shaped by Bioventus Inc., trading at $9.21. Its intraday range covers from $9.03 up to $9.32, with a daily movement of +0.6637%.

FAQ: Bioventus Inc. (BVS)

What is the current price of BVS stock?

The current price is $9.21.

Does BVS pay dividends?

Bioventus Inc. pays dividends, with distributions via cash distributions (if applicable).

Does BVS have a formal corporate presence or regional headquarters in the UAE?

Bioventus Inc. does not have an official office or subsidiary in the UAE and operates through regional partners.

What is BVS best known for?

It is most famous for its development of orthobiologic products for musculoskeletal healing.

What assets are typically shown together with BVS?

Commonly shown alongside BVS: AGF US Market Neutral Anti-Beta Fund, First Trust Europe AlphaDEX Fund, Standex International Corp